Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratoire M2 is a Canadian biotechnology company that develops and manufactures biodegradable antimicrobial solutions based on its proprietary Thymox technology. The company's products leverage the natural disinfectant properties of thymol, a botanical extract, to provide effective alternatives to harsh chemicals in animal health, crop protection, and industrial disinfection. Their primary commercial focus is on the dairy industry, where they provide treatments for digital dermatitis, and the institutional cleaning sector. Laboratoire M2 is recognized for its commitment to sustainability, offering non-toxic and environmentally friendly biosecurity solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratoire M2.